News Sentiment

DRREDDY sentiment intelligence

Dr. Reddy's Laboratories Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 11 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 1244.30 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 11

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-8.9% over one week, -1.8% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -8.9% Price reacting lower
Trend fit Trend active -1.8% over four weeks
Fair value 1.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 6
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 11
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 3
Stock Titan 1
Investing.com 1
CNBC TV18 1
webull.com 1
GuruFocus 1
DirectorsTalk Interviews 1
Market source 1

Event Lens

What the news is about

Classified themes
Market update 7
Regulatory and legal 1
Macro sensitivity 1
Earnings 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-11 of 11